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ABSTRACT 
Ethambutol is an anti-tuberculosis drug important in treatment of multidrug resistant tuberculosis 
which is on a rise due to emergence of Human Immunodeficiency Virus. However, it has been 
associated with side effects on optic nerve histology leading to severe neuropathy. The purpose of this 
study was to establish the protective potential of Lantana trifolium ethanolic extract against ethambutol 
induced histological changes in the optic nerve. Twenty five male adult wistar rats of 110-130g average 
weight were used. These were divided into five groups each comprising five animals. Group A received 
distilled water only. Group B was treated with 100 mg/kg/day of ethambutol. Groups C, D, and E were 
treated with 25, 50, and 100 mg/kg/day of Trifolium Extract respectively, one hour before 
administering 100 mg/kg/day of ethambutol. After five weeks the optic nerves were excised, processed 
and stained for histological studies. It was observed that Lantana trifolium ethanolic extract had a dose 
dependent protective potential against ethambutol induced histological changes in the optic nerve. The 
histology of the optic nerve showed that the numbers of vacuoles were significantly few in group A 
(2.2±0.37), D (6.2±1.07), and E (5±0.71) when compared against the positive control group 
(37.4±1.54). Axons were mildly demyelinated in group D and E compared to group B and C. The 
protective potential of Latana trifolium is possibly present due to its anti-oxidative and anti-
inflammatory activities. Studies to determine the exact phytochemical component and mechanism of 
action responsible for the neuroprotective potential of Latana trifolium should be conducted.  
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INTRODUCTION 
Ethambutol (EMB) is one of the first line drugs 
for treating tuberculosis (TB) (Biadglegne et al., 
2014) [1]. It broadens the resistance spectrum 
and prevents development of resistance to 
companion drugs (Lacoma et al., 2015) [2]. 
Regardless of these desirable characteristics, 
EMB is known to cause histological changes in 
the optic nerve that result into optic neuropathy 
(Wang et al., 2012) [3]. This was established 
soon after its discovery in 1960s as a promising 
agent to treat tuberculosis (Forbes et al., 1962) 
[4]. Ethambutol induced optic neuropathy is 
classically described as reversible on 
discontinuation with complete recovery over 
period of weeks to months (Holla at al., 2015) 
[5]. However worsening of vision after EMB 
discontinuation is also documented (Garg et al., 
2015) [6]. There are reports of some patients 
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who develop severe, irreversible visual 
impairment despite frequent monitoring and 
standard dosages (Chen et al., 2015) [7]. 
Worldwide 100,000 people are estimated to 
lose vision completely each year due to the use 
of EMB (Bourne et al., 2013) [8]. This number 
may increase due to prolonged use of anti TB 
drugs in HIV/AIDs patients and those with 
relapses.  
The exact mechanism of  how EMB induces 
optic neuropathy has not been confirmed 
(Palomino and Martin, 2014) [9]. However it 
has been stipulated that it is due to the 
chelating effects of EMB and its metabolites 
that interfere with several mitochondrial metal 
containing enzymes (Rasool et al., 2015) [10]. 
This causes interruption of mitochondrial 
function and oxidative phosphorylation that 
result into optic nerve damage (Kinoshita et al., 
2012) [11]. The symptoms of EMB induced 
toxic optic neuropathy are painless, symmetrical 
and progressive (Rasool et al., 2015) [10]. The 
condition is underdiagnosed and the diagnosis 
is mostly done when recovery of vision is 
impossible (Jeanjean and Dupeyron, 2014) 
[12]. Moreover there are no preventive and 
treatment measures for EMB induced optic 
neuropathy up to date (Yang et al., 2016) [13]. 
It is therefore necessary that studies to find a 
remedy for the toxic effects of EMB are carried 
out, of which Lantana trifolium leaf extract can 
be one of the remedies. 
Lantana trifolium known as Kayukiyuki 
(Luganda), Omuhuuki (Runyankore) belongs to 
the family of Verbenaceae (Nalubega et al., 
2011) [14]. It is a three leafed, scrambling, 
evergreen shrub growing up to 3 meters tall in 
all subtropical and tropical regions (Schemske, 
1976) [15]. In Uganda, leaves of Lantana 
trifolium have been used to treat eye conditions 
such as blindness, glaucoma, conjunctivitis, and 
bacterial and viral eye infection (Ocheng et al., 
2014) [16]. Previous studies have reported that 
Lantana trifolium  extract has anti-oxidative, 
anti-inflammatory, anti-nociceptive and sedative 
activity in experimental animals (Silva et al., 
2005) [17]. The few studies that have been 
carried out on the chemistry of Lantana 
trifolium show that its biological activities are 
associated with its components mainly the 
phenols, phenylpropanoids, flavonoids and 
terpenoids (Imbenzi et al., 2014) [18]. The aim 
of this study was to establish the 
neuroprotective potential of Lantana trifolium 
ethanolic extract against ethambutol induced 
histological changes in the optic nerve. 
 
 
MATERIALS AND METHODS 
Animals 
This experimental design involved 25 male 
adult wistar rats of 110-130g average weight. 
These were obtained from the animal facility at 
Kampala International University (KIU).  They 
were housed in cages, exposed to 12 hour of 
dark and light cycles. They were fed on 
commercial rat pellets (Nuvita Feeds- Kampala, 
Uganda) and provided with tap water ad 
libitum. Animals were randomly divided into five 
groups of five rats each. Group A, the negative 
control group received distilled water. Group 
B, the positive control group received EMB at 
dose of 100mg\kg\day orally for five weeks. 
Groups C, D and E received Lantana trifolium 
ethanolic extract at doses of 25mg\kg\day, 
50mg\kg\day and 100mg\kg\day orally 
respectively one hour before orally receiving 
EMB at doses of 100mg\kg\day for five weeks. 
Ethical Considerations 
This study was approved by the Directorate of 
Postgraduate Studies and Research of Kampala 
International University Western Campus. All 
animal studies that were carried out in this 
experiment were conducted in accordance with 
“Guide for Care and use of Laboratory Animals” 
(National Research Council, 2010) [19]. A 
minimum number of animals were used in the 
study and inflicting pain to the animals was 
minimized by sacrificing them under 
anaesthesia. EMB toxicity is not contagious, 
thus experimental animals were not harmful to 
people and environment. 
 





Leaves of the plant were collected early in the 
morning and packed in a black polythene bag, 
from Bushenyi district in western Uganda. A 
sample of the fresh and a shade dried plant 
was taken to Makerere University Herbarium for 
identification by a Botanical Taxonomist Dr. 
Mary Namaganda. It was identified as Lantana 
trifolium and given a collector number OE 
#001. A sample of this was kept for future 
references. 
Preparation of the Extract 
The leaves were properly washed with tap 
water before shade drying, and then ground 
using a motor and pestle. The powdered 
material was put in the thimble and loaded into 
a Soxhlet apparatus for ethanolic extraction at a 
temperature of  80 °C (Luque-decastro and 
Priego-capote, 2010) [20]. The extract was 
filtered through a watmann filter paper (125 
mm) and concentrated using a rotary 
evaporator maintained at 40 °C. Using a water 
bath, the concentrated extract was evaporated 
to dryness and stored in a refrigerator at 4°C.  
Administration of Ethambutol and 
Lantana Trifolium Ethanolic Extract 
Ethambutol (Cosmos Limited- Nairobi, Kenya) 
and plant extract were each dissolved in 
distilled water and then administered once daily 
using oral gavage. Ethambutol was 
administered one hour after Lantana trifolium 
administration. The dose of EMB and plant 
extract given to each of the animals was 
calculated using the standard formula below. 
Dose given = dose (mg/kg) x animal weight(g)    
Concentration (mg/ml) x 1000. 
(Ninsiima et al., 2016) [21]. 
 
Histological analysis of the optic nerve 
The animals were deeply anesthetized by 
placing them in a transparent air tight container 
having cotton soaked with 1.9% of ether.  An 
incision was made in the skin overlying cervical 
region when the animals were unconscious. 
Using surgical blade, forceps and scissors for 
dissection the scalp was removed exposing the 
skull cap.  This was detached from the dura 
mater and the calvarium lifted to expose the 
brain. The falx cerebri was pulled posteriorly, 
away from the crista galli. The frontal lobes 
were raised from the anterior cranial fossa, 
incised and removed to expose the optic nerves 
along with the chiasma (Heffner et al., 1980) 
[22]. Both optic nerves were cleanly dissected 
(fig. 1), incised proximal to the optic chiasma 
and then removed along with the eye balls. 
They were fixed immediately with 4% 
paraformaldehyde in phosphate buffer saline 
(PBS). Tissues were post fixed in 2% osmium 
tetroxide in PBS for 2 hours. These were then 
processed for histological examination using an 
automated tissue processor (Histokinette-SLEE 
MAINZ, MTP type).  After which they were 
placed vertically in the center of embedding 
moulds and molten paraffin wax was used for 
embedding. Sections of 10μm and 3μm 
thickness were cut from the cold tissue blocks 
using a rotatory microtome (SLEE MAINZ, 
CUT4062 model) and stained using Luxol fast 
blue (LFB) stain, Hematoxlyin and Eosin 
respectively (Kiernan et al., 2010) [23]. The 
slides were examined under a light microscope 
(Nikon Eclipse Ci, 104C type) using X40 
objective and the observations recorded.  
Photomicrographs were taken using a mounted 
digital camera (Nikon digital sight DS, Fi 1) 
attached to a computer with software (NIS-
Elements F3.00, SP7; Build 547). 
Data Analysis 
The number of vacuoles observed in the 
photomicrographs were counted using ImageJ 
2015 (Fiji). Using graph pad prisms V6, mean ± 
SEM were obtained for the number of vacuoles, 
and then analysis of variance (ANOVA) was 
applied to determine group mean differences 
between the control and test groups. A post-
HOC Tuckey test was used to determine 
differences in group means considering a p-









In this study trifolium extract (TE) showed a 
dose dependent protective effect. Varying 
numbers of vacuoles were observed in the optic 
nerves of all the groups (fig. 2). The number of 
vacuoles in positive control group (37.4±1.54) 
and; the group that received EMB and 25mg/kg 
TE (36±1.30) were significantly high (P<0.05) 
when compared to the number of vacuoles in 
the negative control group (2.2±0.37). The 
number of vacuoles in the groups treated with 
EMB and 50mg/kg TE (6.2±1.07) and; EMB and 
100mg/kg TE (5±0.71) were significantly few 
(P<0.05) when compared to those in the 
positive control group. Demyelination was not 
observed in the optic nerve axons of the 
negative control group (fig. 6). However 
varying degrees of demyelination were 
observed in the remaining groups. Axonal 
demyelination was severe in the axons of the 
optic nerves of the positive control group and; 
the group treated with EMB and 25mg/kg TE 
(fig. 7). Axonal demyelination was mild in the 
groups treated with EMB and 50mg/kg TE and; 
EMB and 100mg/kg TE (fig. 8). 
 
Figure 1: Photograph Showing the Eye Ball (EB), and 
Arrows Pointing at Optic Nerve (OPN) and Optic Chiasma 
(OC) in Situ after Removing the Brain. 
 
 
Figure 2: A Bar Graph Showing Number of Vacuoles in the Optic Nerve Cross Section. EMB = Ethambutol; TE = 
Trifolium Extract. Multiple comparisons; against the negative control group ****P<0.0001; against positive control group, 
####P <0.0001.   
DISCUSSION 
Latana trifolium extract had a dose dependent 
neuroprotective potential against EMB induced 
histological changes in the optic nerve. The 
extract showed a dose dependent protection 
against optic nerve vacuolation and axonal 
demyelination. In this study vacuoles were 
observed in the optic nerves of all the groups. 
However there were significant differences in 
the number of vacuoles from the different 
groups (fig. 3, 4 & 5). The few vacuoles 
observed in the negative control group are as a 
result of apoptosis (Sadun, 2012) [24]. The 
highest  













A: Photomicrographs of Optic Nerve Cross Section from Group A Showing a few Vacuoles (V). H & E Stain, 
X40. B: Photomicrographs of Optic Nerve Cross Section from group B Showing Many Vacuoles (V). H & E 
Stain, X40. C: Photomicrographs of Optic Nerve Cross Section from Group E Showing a Few Vacuoles (V) 
Comparable to Those in Group A. H & E Stain, X40. D:  Photomicrographs of Optic Nerve Cross Section from 
Group A Showing Normal Myelinationed Axons. LFB Stain, X40. E:  Photomicrographs of Optic Nerve Cross 
Section from Group B Showing Severe Axonal Demyelination. LFB Stain, X40. F:  Photomicrographs of Optic 
Nerve Cross Section from Group D Showing Mild Axonal Demyelination. LFB Stain, X40.  
 




number (37.4±1.54) was observed in the 
positive control group that received EMB alone, 
this result is consistent with earlier observations 
(Chung et al., 2009) [25]. They reported that 
EMB induced optic neuropathy causes vacuolar 
changes in the optic nerve. No significant (P > 
0.05) difference was found between the 
number of vacuoles in the positive control 
group and; the group treated with EMB and 
25mg/kg TE. However, there was significant 
difference (P<0.05) when the number of 
vacuoles of negative  control group, and the 
groups treated with EMB and 50mg/kg TE and;  
EMB and 100mg/kg TE were compared to those 
of the positive control (EMB only) group.  
Vacuolations show axonal degeneration induced 
by EMB (Zubair et al., 2009) [26]. The exact 
mechanism how EMB induced vacuoles are 
formed has not been confirmed (Fonkem et al., 
2013) [27].  However the suggested 
mechanism is related to the chelating effects of 
EMB and its metabolites that interfere with 
several mitochondrial metal containing enzymes 
(Guillet et al., 2010) [28], such as the iron 
containing complex I and copper containing 
complex IV  (Kinoshita et al., 2012) [11]. This 
interrupts oxidative phosphorylation and 
mitochondrial function leading to adenosine 
triphosphate (ATP) depletion  (Wang et al., 
2012) [3], generation and accumulation of 
reactive oxygen species (ROS) that cause 
oxidative stress in the optic nerve (Areti et al., 
2014) [29]. The resultant effect is anaerobic 
glycolysis, forming lipids inside the axon that 
microscopically appear like vacuoles (Chen et 
al., 2015) [7]. It is speculated that Lantana 
trifolium protected the optic nerve against EMB 
induced vacuolation by interfering with this 
mechanism.  
The protective potential of Lantana trifolium 
against EMB induced optic nerve vacuolations is 
probably as result of its anti-oxidative activity 
which is attributed to its high amounts of 
phenols (Salabarría et al., 2009) [30]. This is 
done through blocking the formation of ROS 
and scavenging them once they have been 
formed by donating electrons to the highly 
reactive free radicals (Perumal et al., 2012) 
[31]. This results into formation of stable 
compounds and thus reduction of oxidative 
stress in the optic nerves. In another study, 
caffeic acid phenethyl ester, a phenolic 
compound found in plants was found to 
significantly decrease vacuolation by preventing 
oxidative stress in the optic nerve of EMB 
treated rats  (Uzar et al., 2014) [32].  
Ethambutol induced severe demyelination of 
the axons as observed in the positive control 
(EMB only) and the group treated with EMB and 
25mg/kg TE groups (fig.7). The result of our 
investigation is consistent with the findings of 
(Han et al., 2015) [33]. However, Zubair et al., 
(2009) [26] reported differing results, they did 
not observe demyelination of the axons after 
four weeks of EMB treatment. This difference 
could be as a result of 1 week difference in the 
duration of the experiments. Demyelination in 
the groups treated with EMB and 50mg/kg TE 
and; EMB and 100mg/kg TE was mild (fig. 8); 
suggesting that Lantana trifolium extract 
effectively protected the optic nerve against 
EMB induced axonal demyelination at doses of 
50mg/kg and 100mg/kg.  
Ethambutol toxicity damages myelin, a fatty 
acid layer produced by the oligodendrocytes 
that surrounds optic nerve axons (Fancy et al., 
2011) [34]. Myelin is responsible for fast 
transmission of signals through the nerves 
(Crawford et al., 2014) [35]. Damage to the 
myelin sheath results into progressive axonal 
loss. A similar mechanism as described above 
of EMB metal chelating effect has been 
suggested as well for its induced axonal 
demyelination (Guillet et al., 2010) [28]. Other 
studies reported that EMB toxicity induces 
demyelination through inhibition of 
phosphorylation by cyclic adenosine 
monophosphate (AMP) dependent protein 
kinase-A (Griffith et al., 2005) [36]. This is the 
same mechanism for phosphorylating myelin 
basic proteins (Chan and Kwok, 2006) [37]. By 
compromising respiratory function, a major 
consequence of reactive oxygen species 
accumulation may generate some 
compensatory proliferation of mitochondria in 
the endothelial and smooth muscle cells of optic 




nerve blood vessels (Osaguona et al., 2014) 
[38]. These changes result into vascular 
inflammation and thus a reduced blood supply 
to the nerve tissue that precedes myelin 
breakdown (Rasool et al., 2015) [10]. 
Since oligodendrocytes are preserved in the 
early stages of demyelination, the myelin 
sheaths around the optic nerve axons can be 
reconstructed after eliminating the cause of the 
myelin damage (Young et al., 2013) [39].  
Therefore it is possible that Lantana trifolium 
ethanolic extract protected the optic nerve 
against EMB induced demyelination by restoring 
oxidative phosphorylation and inhibiting 
inflammation. The plant’s anti-oxidative activity 
has already been mentioned in previous studies 
(Imbenzi et al., 2014) [18]. Lantana trifolium 
ethanolic extract is known for its anti-
inflammatory activity attributed to the high 
flavonoid content (Silva et al., 2005) [17]. The 
mechanism of how it prevents inflammation has 
not been studied sufficiently. However Julio et 
al., (2010) [40] reported that Lantana trifolium 
inhibits inflammation by reducing histamine 
release. 
 
In conclusion, Lantana trifolium ethanolic 
extract had a dose dependent neuroprotective 
potential against ethambutol (EMB) induced 
histological changes in the optic nerve.  The 
potential of Lantana trifolium ethanolic extract 
to protect the optic nerve against EMB induced 
changes could be as a result of its anti-
oxidative and anti-inflammatory activities. 
These have been attributed to the high 
amounts of phenols and flavonoid, components 
of Lantana trifolium phytochemicals.  
 
We recommend that further Studies using 
immunohistochemical techniques to evaluate 
EMB induced histological changes in the optic 
nerve are carried out. Studies should be 
conducted to establish Lantana trifolium’s exact 
phytochemical component and mechanism of 
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